Tech Company M&A Transactions
Synlogic Acquisition
On 5/16/2017, Synlogic was acquired by Mirna Therapeutics. No transaction price was released.
Transaction Overview
Company Name
Acquired By
Announced On
5/16/2017
Transaction Type
M&A
Amount
Unknown
M&A Terms
The merged company will continue under the Synlogic name and will focus on advancing Synlogic's drug discovery and development platform for Synthetic Biotic medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer. Financial terms of the deal were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
301 Binney St. 402
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Synlogic leverages the most advanced technology platform available for the creation of synthetically engineered, therapeutic microbes with the potential to make significant advancements in the treatment of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aoife Brennan
Chief Financial Officer
Todd Shegog
Chief Scientific Officer
Scott Plevy
VP - General Counsel
Maiken Keson-Brookes
VP - Human Resources
Adam Thomas
VP - Operations
Antoine Awad
VP - Product Management
Caroline Kurtz
Browse more venture capital transactions:
Prev: 5/16/2017: AKUA venture capital transaction
Next: 5/16/2017: Razer venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs